Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Scienture Holdings (SCNX) EBT (2016 - 2025)

Scienture Holdings (SCNX) has disclosed EBT for 13 consecutive years, with -$6.7 million as the latest value for Q2 2025.

  • Quarterly EBT fell 313.64% to -$6.7 million in Q2 2025 from the year-ago period, while the trailing twelve-month figure was -$18.0 million through Jun 2025, down 35.36% year-over-year, with the annual reading at -$43.5 million for FY2025, 131.68% down from the prior year.
  • EBT hit -$6.7 million in Q2 2025 for Scienture Holdings, down from -$3.1 million in the prior quarter.
  • In the past five years, EBT ranged from a high of -$340474.0 in Q3 2022 to a low of -$6.7 million in Q2 2025.
  • Historically, EBT has averaged -$2.2 million across 5 years, with a median of -$1.2 million in 2021.
  • Biggest five-year swings in EBT: plummeted 1040.63% in 2021 and later skyrocketed 73.84% in 2022.
  • Year by year, EBT stood at -$784340.0 in 2021, then tumbled by 252.67% to -$2.8 million in 2022, then crashed by 43.67% to -$4.0 million in 2023, then surged by 59.12% to -$1.6 million in 2024, then tumbled by 313.64% to -$6.7 million in 2025.
  • Business Quant data shows EBT for SCNX at -$6.7 million in Q2 2025, -$3.1 million in Q1 2025, and -$1.6 million in Q2 2024.